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a b s t r a c t
Studies have shown that Porcine circovirus (PCV)-2 induces apoptosis in PK15 cells. Here we report that
cell death is induced in PCV2b-infected PK15 cells that express Capsid (Cap) protein and this effect is
enhanced in interferon gamma (IFN-γ)-treated cells. We further show that transient PCV2a and 2b-Cap
protein expression induces cell death in PK15 cells at rate similar to PCV2 infection, regardless of Cap
protein localization. These data suggest that Cap protein may have the capacity to trigger different
signaling pathways involved in cell death. Although further investigation is needed to gain deeper
insights into the nature of the pathways involved in Cap-induced cell death, this study provides evidence
that PCV2-induced cell death in kidney epithelial PK15 cells can be mapped to the Cap protein and
establishes the need for future research regarding the role of Cap-induced cell death in PCV2
pathogenesis.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Porcine circovirus (PCV)-2 has been identiﬁed as the primary
causative agent of Post-weaning Multisystemic Wasting Syndrome
(PMWS), a clinical syndrome of progressive wasting that mainly
affects 6- to 12-week-old pigs (Allan et al., 1999; Bolin et al., 2001).
PMWS is characterized by an extensive lymphoid cell depletion
and granulomatous inﬂammation (Chianini et al., 2003; Darwich
et al., 2002; Sarli et al., 2001) that correlate positively with high
PCV2 viral load in affected animals (Ladekjaer-Mikkelsen et al.,
2002). PCV2 is the smallest known autonomously replicating non-
enveloped virus with a 1.7-kb single-stranded circular DNA gen-
ome, which has three well-characterized open reading frames
(ORFs). ORF1 encodes two proteins involved in genome replica-
tion, Rep and the splice variant Rep', while ORF2 encodes the
dominant immunogenic and only structural capsid protein, Cap
(Nawagitgul et al., 2002). The third ORF encodes a non-structural
protein called ORF3 that has been characterized as a pro-apoptotic
protein (Liu et al., 2005).
Having a limiting coding capacity implies that PCV2 must
encode for multifunctional products to ensure replication within
the host. In fact, beside its role as the only structural protein
involved in virus assembly, PCV2 Cap protein plays a role in
controlling viral replication via its interaction with Rep protein
in the nucleoplasm, may be by inﬂuencing DNA synthesis
(Finsterbusch et al., 2005; Timmusk et al., 2006). Several other
cellular proteins involved in different aspects of viral replication
such as transcriptional regulation and intracellular transport were
also found interacting with Cap protein (Finsterbusch and
Mankertz, 2009). Along the same lines, it has been reported that
PCV2 manipulates the autophagy machinery to enhance viral
replication; and Cap protein was found responsible for that effect,
by promoting the formation of autophagosome (Zhu et al., 2012).
Several studies have linked viral replication with cell death and
viral dissemination, although the outcome seems to be virus and
cell speciﬁc (Berens and Tyler, 2011; Levine and Deretic, 2007).
PCV2 has been shown to induce apoptosis in porcine kidney
epithelial PK15 cells (Liu et al., 2005). On one hand, ORF3 protein
was identiﬁed as a contributing factor to apoptosis in PK15 cells
(Liu et al., 2005); although, its role as the only factor causing
lymphoid depletion has been a subject of controversy (Juhan et al.,
2010). On the other hand, i) enhanced PCV2 replication was
associated with cell death in PCV2 infected cells with a densely
localized, perinuclear Cap protein expression (Dvorak et al., 2013),
and ii) the ability of PCV2 to replicate and to induce cytopathic
effect in the host seems to be compromised by speciﬁc mutations
occurring in Cap protein (Fenaux et al., 2004; Krakowka et al.,
2012). Altogether, these data suggest that PCV2-Cap protein may
be involved in inducing cell death late in the replication cycle.
Here we have investigated the hypothesis that Cap protein holds
the capacity to induce cell death in pig cells, as a result of viral
replication. Our objectives were to determine whether i) enhan-
cing PCV2 replication with interferon gamma (IFN-γ) treatment in
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PK15 cells is associated with death in cells expressing Cap protein
and ii) Cap protein expression alone is capable of promoting the
same effect in the absence of the viral genome and other PCV2
products. Here we report that Cap protein expression induces cell
death in the PK15 cell line and that effect is enhanced by IFN-γ. A
cell death by “bystander” effect has also been observed in cells
devoid of any sign of infection. Our results also show that the
transient PCV2 Cap protein expression induces cell death at similar
rate to PCV2 infection, whether the expression is nuclear or
cytoplasmic, suggesting Cap protein's ability to interact with
different cell death signaling pathways. This study provides the
basis for future research regarding the role of Cap-induced cell
death in PCV2 pathogenesis.
Materials and methods
Generation of recombinant eukaryotic expression vectors
Coding sequences of ORF2 were PCR-ampliﬁed from PCV2a
(GenBank accession number: JQ994269) and PCV2b (GenBank
accession number: JQ994270) strains using oligonucleotide pri-
mers (Table 1). The PCV2a and PCV2b full genomes were cloned in
pcDNA plasmids that have been kindly provided by Dr. Carl
Gagnon (University of Montreal, Quebec, Canada). The anti-sense
ORF2 constructs served as negative experimental controls for Cap
expression. PCR was performed with iProofTM Hi-Fidelity DNA
Polymerase (BioRad, Mississauga, Ontario, Canada) in a Gen-
eAmps PCR System 9700 (PE Applied Biosystems, Carlsbad, CA).
PCR cycle proﬁle consisted of a pre-denaturation step at 98 1C for
30 s followed by 36 cycles of denaturation at 98 1C for 10 s,
annealing at 60 1C for 30 s, extension at 72 1C for 60 s and a ﬁnal
extension step at 72 1C for 10 min. After separation by agarose gel
electrophoresis, PCR products of expected size were puriﬁed using
a QIAquicks Gel Extraction Kit (QIAGEN). The NotI/SalI fragments
of ORF2 were cloned into the corresponding sites of the eukaryotic
expression plasmid pCI (Clontech, Mountain View, CA) under the
control of a human cytomegalovirus (CMV) promoter (pCMV-
PCV2bCap). A pCMV-HA plasmid (Clonetech, Mountain View, CA)
was used to clone the full length and truncated Cap without the
nuclear localization signal (ΔNLS-2bcap) under CMV promoter
and HA tag. The ﬁrst 41 amino acids at the N-terminal of full
length Cap (Liu et al., 2001) were removed using suitable primers
(Table 1) to generate ΔNLS-2bcap fragment. The NotI/SalI frag-
ments of full length Cap and ΔNLS-2bcap were cloned into the
corresponding sites of the pCMV-HA. The resulting clones pCMV-
HA-2bcap and pCMV-HA-ΔNLS-2bcap were conﬁrmed by sequen-
cing and the expression was conﬁrmed by western blot using
Rabbit anti-PCV2b-Cap. The ORFs cloned in this vector are
expressed under CMV promoter in mammalian cells as a tagged
protein with a N-terminal HA-tag.
Cell culture
PCV-free porcine kidney epithelial PK-15 cell line was main-
tained in growth media (Eagle's minimum essential medium
(Invitrogen), 10% fetal bovine serum (FBS) (Invitrogen), 2% peni-
cillin–streptomycin solution (Invitrogen), 1% sodium pyruvate
(Invitrogen), 1% essential amino acids (Invitrogen). The human
embryonic kidney epithelial 293T cell line was grown in Dulbec-
co's modiﬁed Eagle medium (Invitrogen) supplemented with 10%
FBS and 2% penicillin–streptomycin solution.
Infection and transfection
9104 TCID50 of PCV2b were used to infect 60–70% conﬂuent
PK15 cells in 12-well plates. Cells were incubated for 90 min at
37 1C in 5% CO2, and fresh culture medium was then added to
PCV2b infected cells, which were further incubated for 48 h. For
the purpose of increasing viral replication, PK15 were also treated
with 500 U/ml of swine recombinant IFN-γ (Gibco) before or after
PCV2b infection. Non-infected PK15 cells treated with IFN-γ were
used as control. For transfection experiments, 12-well plates
(3.8 cm2 per well) were coated with poly-D-lysine (Sigma-Aldrich)
and cells were seeded one day prior to transfection in growth
medium without antibiotics (1 ml per well in a 12-well plate).
When the cells were 70% to 80% conﬂuent, 2 μg of DNA was
transfected into the cells with Lipofectamine 2000 (Invitrogen,
Burlington, Ontario, Canada). The growth media is added 4 h post-
transfection and cells were analyzed 48 h later.
Flow cytometry-based intracellular staining of the cap expression
Mock and PCV2b-infected or transfected cells were trypsinized
and washed with phosphate-buffered saline (PBS). For intracellular
staining, cells were ﬁxed in 4% formaldehyde and cell count was
determined using Petroff-Hausser Chamber (Hausser Scientiﬁc Part-
nership) and phase contrast microscopy (CKX41, Olympus Canada).
Cell were diluted to 106 cells/ml with PBS, treated with the
permeabilization buffer (PBS, 0.1% saponin, BSA) for 30 min at RT
and stained for intracellular Cap expression using a rabbit polyclonal
anti-PCV2b Cap as a primary antibody (1:7290) and Goat anti-Rabbit-
FITC as a secondary antibody. The samples were analyzed by ﬂow
cytometry (Cell Lab quanta TM SC MPL, Beckman Coulter, Canada).
Cell cytotoxicity analysis
All cells including both detached and adherent cells were
collected, centrifuged at 2000 rpm for 5 min and washed twice
with PBS. The concentration was adjusted to 106 cells/ml. For each
treatment, 100 μl of cell suspension was stained using molecular
probess live/deads ﬁxable dead cell stain kits (Invitrogen) accord-
ing to the manufacturer's protocol. The cells were then ﬁxed with
4% formaldehyde and intracellular staining for Cap was done as
described above. The samples were analyzed by ﬂow cytometer and
percentage of live/dead cells among the Cap expressing cells were
calculated. Etoposide (Sigma-Aldrich), an apoptosis-inducing che-
mical, was used as a positive control in this assay.
Immunoﬂuorescence assay (IFA)
For Cap protein localization study, PK15 and 293T cells were
washed with PBS and ﬁxed with 4% paraformaldehyde for 30 min
at room temperature (RT). Cells were washed with PBS and treated
with the permeabilization buffer (PBS, 0.1% saponin, BSA) for
30 min at RT. The cells were incubated with a polyclonal rabbit
anti-PCV2b Cap primary antibody (1:200-dilution) at 37 1C in dark
for 90 min. Cells were washed three times with PBS-T (PBS, 0.1%
Table 1
Oligonucleotide primers used to generate/sequence recombinant Cap constructs.
Constructs Primer Sequence (50 to 30)
PCV2a Cap (sense) CCAAGGAGG
R-AGTCGCGGCCGCTTCATTTAGGGTTTAAGTGGG
PCV2b Cap (sense) F-AGTCGTCGACTATGACGTATCCAAGGAGG
R-AGTCGCGGCCGCGAGTTAAGGGTTAAGTGGG
PCV2a Cap (anti-sense) F-AGTCGCGGCCGCTATGACGTATCCAAGGAGG
R-AGTCGTCGACTTCATTTAGGGTTTAAGTGGG
PCV2b Cap (anti-sense) F-AGTCGCGGCCGCTATGACGTATCCAAGGAGG
R-AGTCGTCGACGAGTTAAGGGTTAAGTGGG
ΔNLS-PCV2bCap (SalI) F- AGTCGTCGACTatgAATGGCATCTTCAAC
R-AGTCGCGGCCGCGAGTTAAGGGTTAAGTGGG
HA-pCMV (sequencing primer) GATCCGGTACTAGAGGAACTGAAAAAC
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Tween-20), and were incubated in the dark with Alexa Fluor 568-
conjugated goat anti-rabbit IgG (Molecular probes, Invitrogen) at
37 1C for an hour. Cells were washed three times with PBS-T,
counterstain with 40-6-diamidino-2-phenylindole (DAPI) and
visualized with Olympus IX51 ﬂuorescence microscope.
Statistical analysis
Statistical analyses were performed using SPSS 17.0 software.
Independent samples t-test was performed and differences were
considered signiﬁcant when P-value o or equal to 0.05. At least
three independent trials were conducted for each experiment.
Results and discussion
IFN-γ enhances PCV2 replication that leads to cell death in PK15 cells
It has been shown that PCV2 replication induces apoptosis in
the PK15 cell line (Liu et al., 2005), although it remains unclear
whether cell death is a consequence of direct cytotoxicity, a
“bystander” effect or both. Since IFN-γ is a pro-inﬂammatory
cytokine that has been found to play a role in increasing PCV2
replication in porcine cell lines (Ramamoorthy et al., 2009; Meerts
et al., 2005), PK15 cells were infected with PCV2, treated with IFN-γ
for 48 h, subjected to a double staining with ﬁxable live/dead dye
and anti-Cap antibody and analyzed by ﬂow cytometry. Our results
show an initial rate of infection of 3% in PK15 cells, which increases
to 9% in IFN-γ treated cells regardless of whether the cytokine is
added before or after infection (Fig. 1). We further show that the
2.5- to 3-fold increase in PCV2-Cap positive cells following IFN-γ
treatment was accompanied by a higher rate of cell death when
compared to untreated cells (80% vs. 40%, po0.05) (Fig. 2).
Notwithstanding the limited understanding of how IFN-γ modu-
lates PK15 cells permissiveness to PCV2 (Meerts et al., 2005) and
how this leads to cell death, a study has reported IFN-γ0s ability to
decrease Cyclin A (Cyc A) expression (Sibinga et al., 1999), whose
over-expression suppresses PCV2 replication by altering PCV2-Rep
sub-cellular localization (Tang et al., 2013). The down-regulation of
Cyc A by IFN-γmay lead to cell cycle arrest which in turn can result
in apoptosis-induced cell death. Another study showed that PCV2
activates the Mitogen-Activated Protein Kinase (MAPK) signaling
pathways by phosphorylating Janus Kinases (JNK) 1/2 and p38 that
leads to enhanced viral replication and apoptosis (Wei et al., 2009).
IFN-γ also activates these signaling pathways in macrophage and
endothelial cells, resulting in autophagy activation (Matsuzawa
et al., 2014; Valledor et al., 2008). Thus, it is possible that PCV2
may take advantage of IFN-γ-induced JNK1/2 and p38 activation
and subsequently the autophagy activation to enhance viral replica-
tion leading to cell death. Our results also showed that the IFN-γ
enhances “bystander” cell death in PCV2-Cap negative cells within
PCV2 infected cell cultures (25%) as compared to untreated cultures
(5%) (po0.05), which indicate that IFN-γ may sensitize non-
infected cells to subsequent cell death signals (e.g. Fas-mediated
apoptosis). These ﬁndings raise the possibility that this “bystander”
effect may be taking place in PCV2-infected animals and may
contribute to lymphoid cell depletion in vivo, since a high number
of apoptotic lymphocytes in the lymphoid tissues of PMWS-affected
pigs did not show any sign of productive infection (Shibahara et al.,
2000).
IFN-γ enhances nuclear localization of the PCV2 cap protein
Studies have shown that the nucleo-cytoplasmic shuttling of
viral proteins is a frequent event that accompanies the induction
of apoptosis-induced cell death (Blachon et al., 2005; Heilman et
al., 2006). To determine whether IFN-γ treatment has any effect on
Cap shuttling, cells were infected with PCV2 and were either pre-
or post- treated with IFN-γ and then stained for Cap protein
expression. Our results show a clear change in the intracellular
distribution of Cap protein 48 h post-infection, with a major shift
in the ratio of cytoplasmic-to-nuclear Cap protein localization
from 2:1 in untreated cells to approximately 1:11 in IFN-γ pre-
treated cells and 1:5.6 in IFN-γ post-treated cells (Fig. 3). Although,
PCV2-Cap has an NLS that tags this protein for nuclear transloca-
tion (Cheung and Bolin, 2002), the exact mechanism behind the
nuclear import of Cap protein remains unclear. It was hypothe-
sized that the phosphorylation of the NLS regulates the import of
NLS cargo proteins through nuclear pores (Harreman et al., 2004).
Whether the Cap-NLS has a kinase phosphorylation site or
whether the phosphorylation of NLS may enhance or decrease
the nuclear localization is unknown.
PCV2-cap protein expression induces cell death
To rule out the possibility that the PCV2 induced-cell death
might be due to ORF3 expression, we sought to determine whether
the expression of PCV2-Cap protein expression alone is capable of
inducing cell death in the absence of viral replication. To mimic the
late stage of PCV2 infection, the Cap protein of PCV2a and PCV2b,
Fig. 1. IFN-γ effect on PCV2 replication in PK15. Mock- and PCV2-infected cells
were pre- and post-treated with 500 U/ml of IFN-γ. Cells were collected 48 hpi,
processed for indirect intracellular staining of Cap protein and analyzed by ﬂow
cytometry. Results are expressed as the mean7SD from three independent
experiments.
Fig. 2. IFN-γ effect on cell death in PCV2 infected PK15. Mock- and PCV2-infected
PK15 cells were pre- or post-treated with 500 U/ml of IFN-γ. Cells were collected
48 hpi and stained using molecular probess live/deads ﬁxable dead cell stain kits
(Invitrogen) followed by a staining for Cap protein expression. Cell death values
that are signiﬁcantly different (Po0.05) from the cell death values of non-treated
control (n) are indicated above the bars.
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the two major pathogenic genetic variants that differ only in the
Cap amino acid sequence, was expressed under the control of the
CMV promoter and used to transiently transfect PK15 and 293T
cells. Cells were collected 48 h post-transfection and analyzed by
ﬂow cytometry for cell death and Cap protein expression. Regard-
less of which PCV2 variant had been used for transfection, cell death
was induced in 60% of PK15 cells expressing Cap protein with the
same extent as etoposide (a potent inducer of cell death), (Fig. 4).
Neither PCV2 Cap transfection nor etoposide treatment were strong
inducers of cell death in human 293T cells (Fig. 4), despite a 4- to 5-
fold higher rate of expression of Cap protein in 293T cells (20–30%)
as compared to PK15 cells (5-6%) (Fig. 5). The difference in
cytotoxicity of PCV2-Cap between PK15 and 293T cell lines cannot
be explained by the levels of Cap expression, as both PCV2a- and
PCV2b-Cap constructs expressed the protein at a very similar level
in both cell lines (data not shown). These data suggest that 293T
cells may be speciﬁcally resistant to the PCV2-Cap protein effect, as
they had been previously found to be sensitive to the pro-apoptotic
effect of PCV2-ORF3 (Chaiyakul et al., 2010), and which further
indicate that the mechanism through which PCV2-ORF3 and PCV2-
Cap induce cell death may be distinct. The ability of Cap protein
alone to induce cell death suggests that PCV2-induced apoptosis
may reﬂect the need for Cap protein accumulation late in the
replication cycle to induce cell death. No difference between PCV2a
and PCV2b Cap cytotoxicity in transfected PK15 and 293T cells,
although the ability of these two strains to propagate in VR1BL cells
seems to be different (Dvorak et al., 2013). It has been suggested
that the difference in the replication kinetic of PCV2 strains can be
Fig. 3. Subcellular localization of Cap protein expression in PCV2b-infected PK15 pre- or post-treated with IFN-γ. The PCV2b infected PK15 cells were pre- or post-treated
with 500 U/ml IFN-γ analyzed by IFA for Cap protein expression 48 h later. Representative images of three independent experiments are shown. Cap staining (red) in
different treatment groups was visualized with Olympus IX 51 ﬂuorescence microscope. Blue represents nuclei stained with DAPI. Using Image J analysis the percentage of
Cap nuclear and cytoplasmic staining was studied, cytoplasmic localization (C) of Cap, nuclear localization (N). Statistics of localization of Cap ﬂuorescence was performed on
six different randomized ﬁelds under ﬂuorescent microscope.
Fig. 4. Cell death in PK15 and 293T cell lines tranfected with PCV2a and PCV2b-
Cap. PK15 and 293T cells were transfected with full length Cap-ORF from PCV2a
and PCV2b under the CMV promoter. Empty pCI plasmid and antisense Cap-ORF's
(AS) were used as negative controls and etoposide (50 μM and 100 μM) was used as
a positive control. Cells were collected 48 h after transfection and stained using
molecular probess live/deads ﬁxable dead cell stain kits (Invitrogen) followed by
staining for Cap protein expression. Values that are signiﬁcantly different (Po0.05)
from the values for negative controls, e.g., mock- or antisense controls (n) are
indicated above the bars. This is a representative data set from one of three
independent experiments. Error bars represent the mean standard deviation of
intra-assay replicates.
Fig. 5. Cap protein expression in PK15 and 293T cells. PK15 and 293T cells were
transfected with full length Cap-ORF from PCV2a and PCV2b under the CMV
promoter. Cells were collected 48 hpi, processed for indirect intracellular staining
of Cap protein and analyzed by ﬂow cytometry. Results are expressed as the
mean7SD from three independent experiments.
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compromised by a lower efﬁciency of PCV2 entry or Cap protein
susceptibility to serine proteases cleavage that occurs in the
endosome-lysosome system upon infection (Misinzo et al., 2008).
Although further comparative analysis of Cap protein-induced cell
death from different strains is needed, our data provide evidence
that cytotoxicity can be mapped to the Cap protein and can be cited
as a virulence determinant for PCV2.
Cell death is not dictated by speciﬁc cap protein sub-localization
Given that i) PCV2 replicates in PK15 but not in 293T cells
(Hattermann et al., 2004), ii) Cap protein is expressed in both PK15
and 293T cells and iii) cell death is induced only in PK15 but not in
293T cells prompted us to investigate whether the difference
between PK15 and 293T cells observed with regard to cell death
is due to speciﬁc sub-cellular localization of Cap protein. The PK15
and 293T transfected cells were collected, assessed for Cap protein
expression by IFA and a difference in the Cap protein sub-cellular
localization has been found between PK15 and 293T cells. Inter-
estingly enough, Cap protein was localized preferentially in the
nucleus of PK15 cells (Fig.6), whereas its expression was predo-
minantly cytoplasmic in 293T cells (Fig.6). Next we sought to
analyze whether the nuclear localization of Cap protein was
associated with cell death in PK15. For this purpose, we generated
a construct to express a truncated form of Cap protein devoid of
NLS, this deletion will restrict the expression to the cytoplasm (Liu
et al., 2001). Both PK15 and 293T were transfected with pCMV-
HA-2bcap and pCMV-HA-ΔNLS-2bcap and analyzed for Cap pro-
tein expression and cell death. Our data shows that the truncated
form of Cap was expressed in the cytoplasm, whereas the full
length Cap protein was detected predominantly in the nucleus
(Fig.7). Of note, the expression of Cap protein using pCMV-HA-
2bcap and pCMV-HA-ΔNLS-2bcap constructs induce similar cell
death rate in transfected PK15 cells (Fig. 8), suggesting that the
cell death in our cell model is not dictated by speciﬁc Cap protein
cell localization. This seems also to be true for PCV2 infected cells
pre or post-treated with IFN-γ. Although, a difference was
observed in the cytoplasmic-to-nuclear Cap protein localization
ratio between IFN-γ pre- or post-treated cells (1:11 vs. 1:5.6),
similar induced-cell death rate has been observed. These data
suggest that Cap protein is capable of triggering different cell
death signaling pathways in PK15 cells. Studies have indeed
demonstrated Cap protein localization in the nucleoli, recognized
as a site for ribosome biogenesis, which also holds components
Fig. 6. Sub-cellular localization of Cap protein in PK15 and 293T cells. Recombinant construct with PCV2b-Cap under CMV promoter was transfected into PK15 and 293T
cells. Cells were collected 48 h and analyzed by IFA. Representative images of three independent experiments are shown. In PK15 cells the Cap is localized predominantly in
the nucleus (4Nn), whereas in 293T (4Cn) cells it is mostly cytoplasmic.
Fig. 7. Sub-cellular localization of Cap protein in PK15 under HA tag. (a) Full length PCV2bCap (HA-2b) and (b) truncated Cap without NLS (HA-ΔNLS-2b). Recombinant
constructs with full length PCV2b-Cap and PCV2b-Cap without NLS under HA tag and CMV promoter were transfected into PK15 cells. Cells were collected 48 h post-
transfection and analyzed by IFA. The full length Cap protein is observed in different subcellular levels cytoplasm(Cn), nucleus (Nn) and also in the nucleolus (Nun) of some
cells. In the absence of NLS the Cap is localized in the cytoplasm (Cn) alone.
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that play a role in executing active cell death (Horký et al., 2002).
In addition, virus-like particles have been shown to interact
with the inner and outer membranes of mitochondria, the cellular
organelles intrinsically involved in the apoptotic pathway
(Rodriguez-Cariño and Segalés, 2009; Rodríguez-Cariño et al.,
2010).
We conclude that Cap protein individually expressed has the
ability to induce cell death in PK15 cells, and that effect may
account for nearly all the cell death observed in PCV2 infected
cells. The Cap protein's ability to cause cell death regardless where
it is expressed raises the possibility that cell death may be
triggered in the nucleus by immature virions and enhanced by
mature virions in the cytoplasm to promote the virus release.
Although further investigation is needed to gain insights into the
nature of the pathways involved in Cap-induced cell death, this
study provides the basis for future research regarding the role of
Cap-induced cell death in PCV2 pathogenesis.
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